BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 33792103)

  • 1. Contemporary Risk Stratification and Treatment of Chronic Myelomonocytic Leukemia.
    Tremblay D; Rippel N; Feld J; El Jamal SM; Mascarenhas J
    Oncologist; 2021 May; 26(5):406-421. PubMed ID: 33792103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing recognition and emerging therapies argue for dedicated clinical trials in chronic myelomonocytic leukemia.
    Renneville A; Patnaik MM; Chan O; Padron E; Solary E
    Leukemia; 2021 Oct; 35(10):2739-2751. PubMed ID: 34175902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment advances for pediatric and adult onset neoplasms with monocytosis.
    McCullough KB; Kuhn AK; Patnaik MM
    Curr Hematol Malig Rep; 2021 Jun; 16(3):256-266. PubMed ID: 33728588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic myelomonocytic leukemia: 2012 update on diagnosis, risk stratification, and management.
    Parikh SA; Tefferi A
    Am J Hematol; 2012 Jun; 87(6):610-9. PubMed ID: 22615103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic myelomonocytic leukemia: 2024 update on diagnosis, risk stratification and management.
    Patnaik MM; Tefferi A
    Am J Hematol; 2024 Jun; 99(6):1142-1165. PubMed ID: 38450850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic myelomonocytic leukemia diagnosis and management.
    Chan O; Renneville A; Padron E
    Leukemia; 2021 Jun; 35(6):1552-1562. PubMed ID: 33714974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current management of patients with chronic myelomonocytic leukemia.
    Mora E; Sanz GF
    Curr Opin Oncol; 2018 Nov; 30(6):409-417. PubMed ID: 30169461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic myelomonocytic leukemia: 2013 update on diagnosis, risk stratification, and management.
    Parikh SA; Tefferi A
    Am J Hematol; 2013 Nov; 88(11):967-74. PubMed ID: 23963888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes: a focused review.
    Patnaik MM; Lasho T
    Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):460-464. PubMed ID: 33275673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How I treat chronic myelomonocytic leukemia.
    Solary E; Itzykson R
    Blood; 2017 Jul; 130(2):126-136. PubMed ID: 28572287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of cedazuridine/decitabine in the management of myelodysplastic syndrome and chronic myelomonocytic leukemia.
    Thota S; Oganesian A; Azab M; Griffiths EA
    Future Oncol; 2021 Jun; 17(16):2077-2087. PubMed ID: 33709786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic Myelomonocytic Leukemia: 2018 Update to Prognosis and Treatment.
    Elmariah H; DeZern AE
    Curr Hematol Malig Rep; 2019 Jun; 14(3):154-163. PubMed ID: 31093889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current Management and Recent Advances in the Treatment of Chronic Myelomonocytic Leukemia.
    Hunter AM; Zhang L; Padron E
    Curr Treat Options Oncol; 2018 Oct; 19(12):67. PubMed ID: 30367269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current management of patients with chronic myelomonocytic leukemia.
    Alfonso A; Montalban-Bravo G; Garcia-Manero G
    Curr Opin Oncol; 2017 Jan; 29(1):79-87. PubMed ID: 27849645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-world data of chronic myelomonocytic leukemia: A chinese single-center retrospective study.
    Ma L; Jiang L; Yang W; Luo Y; Mei C; Zhou X; Xu G; Xu W; Ye L; Ren Y; Lu C; Lin P; Jin J; Tong H
    Cancer Med; 2021 Mar; 10(5):1715-1725. PubMed ID: 33559357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic myelomonocytic leukemia: 2018 update on diagnosis, risk stratification and management.
    Patnaik MM; Tefferi A
    Am J Hematol; 2018 Jun; 93(6):824-840. PubMed ID: 29878489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic Myelomonocytic leukemia: 2020 update on diagnosis, risk stratification and management.
    Patnaik MM; Tefferi A
    Am J Hematol; 2020 Jan; 95(1):97-115. PubMed ID: 31736132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytogenetic risk stratification may predict allogeneic hematopoietic stem cell transplantation outcomes for chronic myelomonocytic leukemia.
    Motohashi K; Fujisawa S; Doki N; Kobayashi T; Mori T; Usuki K; Tanaka M; Fujiwara S; Kako S; Aoyama Y; Onoda M; Yano S; Gotoh M; Kanamori H; Takahashi S; Okamoto S;
    Leuk Lymphoma; 2018 Jun; 59(6):1332-1337. PubMed ID: 29032731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic Myelomonocytic Leukemia: Focus on Clinical Practice.
    Patnaik MM; Tefferi A
    Mayo Clin Proc; 2016 Feb; 91(2):259-72. PubMed ID: 26848006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic myelomonocytic leukemia - a review.
    Thomopoulos TP; Bouhla A; Papageorgiou SG; Pappa V
    Expert Rev Hematol; 2021 Jan; 14(1):59-77. PubMed ID: 33275852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.